RE:Production capacity -Wuxipalinc2000 wrote: Is there hard evidence to really know how many patients can be treated out of the existing facilities?
Its relatively easy to workout potential production capacity of monoclonal antibodies with some wobble.
The basic number is protein yield per litre. We dont know the specific yield for trogarzo but most antibodies fall within a yield range of 1-5g/litre
Cell cultures take two weeks, so a single bioreactor can theoretically handle 26 batch runs per year.
Trogarzo is produced in 2000l bioreactors and I believe Wuxi have 20 2000l bioreactor but they have been constantly expanding their capacity over the past couple of years.
When I crunched the numbers it looked to me that one 2000l bioreactor LIKELY covers 1500 patients if it solely was used to produce Trogarzo.
Its unlikely that Wuxi's ABSOLUTE capacity is 1500 patients but its possible that the contract between Wuxi and Taimed only covers that amount.
The short answer to your question : no I have no hard evidence.